Abstract
A patient with diffuse angiokeratomas of the lower abdomen and genital region was diagnosed with Fabry disease on the basis of genetic testing. Fabry disease is an X-linked lysosomal storage disease that can affect several organ systems including the heart or kidneys, resulting in reduced median survival. Pathogenetically, Fabry disease leads to a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-GAL A). Treatment options include lifelong enzyme replacement therapy or chaperone therapy.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| ISSN: | 0020-9554 | 
| Sprache: | Deutsch | 
| Dokumenten ID: | 85096 | 
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022 09:13 | 
| Letzte Änderungen: | 25. Jan. 2022 09:13 | 
		
	